Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)

BACKGROUND AND PURPOSE: Clinical trials have demonstrated improved 90-day outcomes for patients with acute ischemic stroke treated with stent retriever thrombectomy plus tissue-type plasminogen activator (SST+tPA) compared with tPA. Previous studies suggested that this strategy may be cost-effective...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Stroke
Autores principales: Shireman, Theresa I., Wang, Kaijun, Saver, Jeffrey L., Goyal, Mayank, Bonafé, Alain, Diener, Hans-Christoph, Levy, Elad I., Pereira, Vitor M., Albers, Gregory W., Cognard, Christophe, Hacke, Werner, Jansen, Olav, Jovin, Tudor G., Mattle, Heinrich P., Nogueira, Raul G., Siddiqui, Adnan H., Yavagal, Dileep R., Devlin, Thomas G., Lopes, Demetrius K., Reddy, Vivek K., de Rochemont, Richard du Mesnil, Jahan, Reza, Vilain, Katherine A., House, John, Lee, Jin-Moo, Cohen, David J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5461963/
https://ncbi.nlm.nih.gov/pubmed/28028150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.014735
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares